Second Opinion March 21, 2025
Guest author Halle Tecco’s breakdown of how the companies valued at more than $1b at the peak are faring — TLDR, the results surprised her!
Editors’ note: Halle Tecco wrote this piece and published it on her website. I liked it so much that I asked her to share it for our audience on Second Opinion, and she agreed! I hope you enjoy it as much as I did! For our next project, Halle and I are looking to develop a list of quiet success stories in health-tech to balance out all the skepticism we’re seeing in the ether. Are you aware of a privately-held health-tech company that’s quickly hit $100m in revenue? And is demonstrating exciting growth? We’re...